HPV vaccines: Additional call-to-action by healthcare providers needed
Although the quadrivalent HPV vaccine was approved for use in the US in 2006, the latest Centers for Disease Control and Prevention (CDC) data shows only 57% of females and 35% of males received at least 1 dose, with far less finishing the three dose series. In fact, the HPV vaccine has the lowest completion rates of any vaccine in the United States, including vaccines that are recommended for the same age groups. In 2013, the Director of the CDC said achieving higher HPV vaccination rates was a top public health priority. Still, achieving higher rates has been a struggle.
Governor Sandoval Declares Nevada Infant Immunization Week – April 18-25
Nevada Governor Brian Sandoval has proclaimed April 18 – 25 Nevada Infant Immunization Week, to coincide with the annual national observance of National Infant Immunization Week (NIIW).
The state and national observance of NIIW highlights the importance of protecting infants from vaccine-preventable diseases and celebrates the achievements of immunization programs in promoting healthy communities throughout the United States.
KNPR State of Nevada: Immunize Nevada Launches HPV Vaccine Campaign
When we hear about HPV – the more common term for the human papillomavirus, the conversation usually focuses on young women and the risk of cervical cancer. In reality, HPV is a much larger health issue for women and men. Some even go so far as to say it is a crisis.
"It's Dismal" Says Health Official About Nevada's HPV Vaccination Rate
When we hear about HPV, the conversation often focuses on young women and the risk of cervical cancer. In reality, HPV is a much larger health crisis for women and men linked to many other diseases that we struggle to talk openly about, like vaginal and penile cancers.
